DOCSLIB.ORG

The Basics Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Basics Of Genetically Modified Organisms: Good, Bad, or Both? Action Research CME Study by Celina Makowski (Principle Investigator) and the Flagler Hospital CME Committee Informed Consent Study Title: Evaluating the Change in Knowledge, Clinical Practice, and Behavior Outcomes of a Community Hospital’s Enduring Continuing Medical Education Activity on the Topic of Genetically Modified Organisms. Study type: Action Research Researcher: Celina Makowski; employee of Flagler Hospital as Manager, CPPD/CME Researcher contact information: [email protected] or 819-4409 Introduction This enduring continuing medical education (CME) activity was created in partnership by the CME Coordinator and CME Committee as part of a doctoral action research study affiliated with Capella University in the School of Public Service Leadership. The Researcher is employed by Flagler Hospital as the Coordinator of Continuing Medical Education/Medical Librarian. If the professional association causes you discomfort you may decline expressing an interest in this study. The information in these next few slides is provided as a reminder of the informed consent form that was sent to you attached to the Genetically Modified Organisms: Good, Bad, or Both? CME activity announcement/study recruitment flyer. As a reminder, if you have any questions or did not understand something within the consent form, you should stop this CME activity and contact the researcher, Celina Makowski, by calling 819-4409 or via e-mail [email protected]. Do not agree to participate in the study unless your questions have been answered. What is this study about? The researcher wants to learn about the changes in knowledge, clinical practice and behavior of physicians, physicians‟ assistants, nurse practitioners, and hospital staff that complete the continuing medical education activity. Participating in the research study is voluntary. Do you want to be in the research study? • Submit a signed consent form prior to completing the Pre-test and CME activity o To obtain a study consent form Click the consent form link within the CME activity folder OR Contact the researcher, Celina Makowski, at 904-819-4409 or e-mail celina.makowski@flaglerhospital o Signed consent forms can be submitted to the researcher via: o Inter-office mail or drop off in Medical Staff Library o E-mail to [email protected] o Fax to 904-819-5290 Do you have additional questions about the study? • Contact the researcher, Celina Makowski, at 904-819-4409 or e-mail celina.makowski@flaglerhospital As a reminder, you may complete the following CME activity to earn credits without participating in the research study. Pre-Test • Please answer the pre-test questions before starting the CME activity by clicking the Pre-Test link within the CME activity folder or • at https://www.surveymonkey.com/r/GMOpretest Genetically Modified Organisms: Good, Bad, or Both? Activity Release: 01/23/2017 Action Research Study Expiration: 09/01/2017 Activity Expiration: 01/23/2018 Target Audience: All physicians, physicians‟ assistants, nurse practitioners and other healthcare professionals and hospital employees interested in genetically modified organisms. Disclosures: o No Commercial Interest o No relevant financial interest by faculty or CME Committee Planners o No investigational products/products not labeled for use is mentioned within the CME activity. Faculty Celina Makowski, MBA Manager, CPPD/CME Flagler Hospital, Inc. Contact Number: 904-819-4409 E-mail: [email protected] CME Objectives At the conclusion of this activity, participants will be able to: • 1. Define genetically modified organisms (GMO) and the various types of genetic modifications utilized in plants and animals. • 2. Consider the historical and future impact of GMO on the food and pharmaceutical supply. • 3. Discuss the controversial benefits, health risks and conflicts of interest associated with GMO products. • 4. Summarize the various positions and viewpoints of medical and governmental organizations, scientists, and consumers. How To Obtain CME/CEU Credit Complete Pre-Test Complete the CME Activity & read the patient education handout- approximate time 1 hour Complete the Post-Test with a passing score of 80% and activity evaluation via SurveyMonkey® link. Complete the Sustained Knowledge question and post-activity evaluation via SurveyMonkey® link emailed to you approximately 3 weeks after activity completion. Accreditation/Credit Statement Flagler Hospital is accredited by the Florida Medical Association to provide continuing medical education for physicians. Flagler Hospital designates this educational activity for maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Flagler Hospital designates this educational activity for 1.00 CE/U. CE Broker: 50-664 Disclaimer This information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient‟s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by Flagler Hospital. In no event will Flagler Hospital be liable for any decision made or action taken in reliance upon the information provided through this CME activity. Video Sacerdote, A. (n.d.) Fed up!-genetic engineering, industrial agriculture and sustainable alternatives. Retrieved from https://archive.org/details/FedUp-GeneticEngineeringIndustrialAgricultureAndSustainable Video Sacerdote, A. (n.d.) Fed up!-genetic engineering, industrial agriculture and sustainable alternatives. Retrieved from https://archive.org/details/FedUp-GeneticEngineeringIndustrialAgricultureAndSustainable Definitions • The American Heritage® Abbreviations Dictionary ▫ “An organism or microorganism whose genetic material has been altered by means of genetic engineering.” 1 • World Health Organization ▫ “Genetically modified organisms (GMOs) can be defined as organisms (i.e. plants, animals or microorganisms) in which the genetic material (DNA) has been altered in a way that does not occur naturally by mating and/or natural recombination.” 2 • Monsanto Company ▫ “A genetically modified organism (GMO) is any organism the genetics of which have been altered through the use of modern biotechnology to create a novel combination of genetic material. GMOs may be the source of genetically modified food ingredients and are also widely used in scientific research and to produce goods other than food.” 3 1. GMO. (n.d.) The American Heritage® Abbreviations Dictionary, (3rd ed). (2005). Retrieved March 12, 2016, from http://www.dictionary.com/browse/gmo 2. World Health Organization. (n.d.). Frequently asked questions on genetically modified foods. Retrieved from http://www.who.int/foodsafety/areas_work/food-technology/faq-genetically-modified-food/en/ 3. Monsanto Company. (2015). Glossary. Retrieved fromhttp://www.monsanto.com/newsviews/pages/glossary.aspx#geneticmodification Purpose of Genetic Modified Crops • Feeding the World of 2050 ▫ Current population is approximately 7.2 billion people 879 million people are currently chronically hungry 2 billion people are malnourished • Farmer benefits ▫ Increase worldwide food supply ▫ Increased crop protection to yield improved productivity Resistant to diseases from pests and viruses Resistant to herbicides for improved weed control Climate change challenges More severe droughts – agriculture uses 70% of fresh water in world • Consumer benefits ▫ Increased food supply equals lower cost ▫ Increased durability of crops reduce food waste ▫ Planned improved nutritional value James, C. (2015). ISAA Brief 49-2014: Executive Summary: Global status of commercialized biotech/GM Crops: 2014. International Service for the Acquisition of Agri-Biotech Application. Retrieved March 6, 2016, from http://www.isaaa.org/resources/publications/briefs/49/executivesummary/default.asp Traditional Methods Genetic alteration of plants and animals • Plants ▫ According to Encyclopaedia Britannica, “plant breeding is the application of genetic principles to produce plants that are more useful to humans. This is accomplished by selecting plants found to be economically or aesthetically desirable, first by controlling the mating of selected individuals, and then be selecting certain individuals among the progeny.” 1 ▫ Dates back to ancient times when people domesticated plants for food ▫ Farmers saved plant seed that had best characteristics for new crops • Animals ▫ According to Encyclopaedia Britannica, “animal breeding is controlled propagation of domestic animals in order to improve desirable qualities.” • Domestication of animals ▫ Pig, to provide food for human consumption ▫ Dog, used as a societal tool, i.e. hunting, protection, companionship • Cross breeding of animals ▫ Cows, to develop stronger, more viable herds ▫ Fish, for increased production • Random trait selection ▫ No direct control of DNA Allard, R. (2015, December 2). Plant breeding. Encyclopaedia Britannica. Retrieved fromhttp://www.britannica.com/science/plant-breeding Freeman, A. (2016). Animal breeding. Encyclopaedia Britannica. Retrieved fromhttp://www.britannica.com/science/animal-breeding Modern Methods • Genetic Engineering ▫ According to Encyclopedia Britannica, “genetic engineering
Load more

Recommended publications
  • U.S. V. Bayer AG and Monsanto Company Comment: the Sierra Club
    ATTN: Kathleen S. O'Neill Chief, Transportation, Energy & Agriculture Section Antitrust Division United States Department of Justice 450 5th Street, NW, Suite 800 Washington, DC 20530 Petition in opposition to proposed U.S. v. Bayer AG and Monsanto Company settlement and merger: A merger of agrochemical giants Bayer and Monsanto would create the world's largest seed and pesticide maker. I am afraid this move will reduce competition, raise prices for consumers and farmers, and result in an unacceptable degree of control over the agricultural industry and our food supply. I am very concerned about pollinators and the increased risks to bees, butterflies and birds with the increase of Bayer's neonicotinoids. Both companies produce corn products engineered to imply the use of harmful pesticides they manufacture. The production of corn uses high amounts of nitrogen- based fertilizers and the excess sediment is contaminating our waterways, therefore I am deeply worried about increased corn production from this merger. The heavy nutrient runoff from corn is widely attributed to exacerbating the marine "Dead Zone" in the Gulf of Mexico, in which algal blooms create hypoxic conditions wherein oxygen concentration is in such low levels that marine life suffocates and dies. I urge the Department of Justice to do more prevent the Bayer-Monsanto seed and pesticide platform from growing too strong by stopping this merger. If this merger is allowed, it should require more pesticide and seed divestments in order to protect our agriculture and food supply. This merger is anti-competition, if it is approved it will fail to protect farmers, consumers and the environment by allowing further consolidation of the industrial agriculture sector.
    [Show full text]
  • Obesity and Nutrients and the Interactions of Environment Factors, Beside Starvation in the World
    Advances in Obesity, Weight Management & Control Review Article Open Access Obesity and nutrients and the interactions of environment factors, beside starvation in the world Abstract Volume 7 Issue 1 - 2017 Basic nutrients are necessary for surviving and healthy life for human. Some of them Necla Çağlarırmak essential food compounds, On the other hand, Nutrition is large and detail term for Food Process Department, Manisa Celal Bayar University, Turkey to be able to explain its meaning because of the main factors; environment, ecology, tradition, economy, education, health events, age steps, special terms of life, gender, Correspondence: Necla Çağlarırmak, Food Process life style, exercise, pregnancy or lactation periods for women etc. All of these factors Department, Manisa Celal Bayar University, Saruhanli College, should interact for each other’s. The environment factors include ecology, climate, Saruhanli-Manisa, Turkey, Email [email protected] geography and tradition for nutrition habits. A typical example is Mediterranean type nutrition or far east nutrition habits. Received: May 28, 2017 | Published: July 11, 2017 Keywords: nutrients, food chemistry, environment, nutrition habits, exercise Introduction If food chemistry and molecular biology are known well, there should be solved an important section of excessive nutrition causing The basic terms and science of health or life sciences related obesity with other affected factors. to obesity places in main nutrients of food chemistry. The main macronutrients are lipids, carbohydrates, protein, micronutrients Food and nutrition pyramids are vitamins and nutritive minerals. Essential food components are Every time nutrient intake must be taken according to food essential fatty acids, essential amino acids, vitamins and minerals. biochemistry and nutrition principles such as food pyramids even Balanced and sufficient diet comprises essential nutrients and enough they can change in the kinds of periods but basically principles are calorie intakes.
    [Show full text]
  • Minnesota FACS Frameworks for Food Science
    FOOD SCIENCE Minnesota Department of Education Academic Standards Course Framework Food Science Program: 090101 Program Name: Food and Food Industries Course Code: 21, 22 Food Science is a course that provides students with opportunities to participate in a variety of activities including laboratory work. This is a standards-based, interdisciplinary science course that integrates biology, chemistry, and microbiology in the context of foods and the global food industry. Students enrolled in this course formulate, design, and carry out food-base laboratory and field investigations as an essential course component. Students understand how biology, chemistry, and physics principles apply to the composition of foods, the nutrition of foods, food and food product development, food processing, food safety and sanitation, food packaging, and food storage. Students completing this course will be able to apply the principles of scientific inquiry to solve problems related to biology, physics, and chemistry in the context of highly advanced industry applications of foods. Recommended Prerequisites: Fundamentals of Food Preparation, Nutrition and Wellness Application of Content and Multiple Hour Offerings Intensive laboratory applications are a component of this course and may be either school based or work based or a combination of the two. Work-based learning experiences should be in a closely related industry setting. Instructors shall have a standards-based training plan for students participating in work-based learning experiences. When a course is offered for multiple hours per semester, the amount of laboratory application or work-based learning needs to be increased proportionally. Career and Technical Student Organizations Career and Technical Student Organizations (CTSO) are considered a powerful instructional tool when integrated into Career and Technical Education programs.
    [Show full text]
  • VIA CERTIFIED MAIL RETURN RECEIPT REQUESTED September 26, 2013 Secretary Vilsack U.S. Department of Agriculture (USDA) Animal He
    VIA CERTIFIED MAIL RETURN RECEIPT REQUESTED September 26, 2013 Secretary Vilsack U.S. Department of Agriculture (USDA) Animal Health and Plant Inspection Service (APHIS) 1400 Independence Ave., S.W. Washington, DC 20250 Petition for Agency Action, Rulemaking, Investigation, and Otherwise Collateral Relief on Recent Genetically Engineered Alfalfa Contamination Introduction Pursuant to the Right to Petition the Government Clause of the United States Constitution,1 the Administrative Procedure Act (APA),2 and United States Department of Agriculture (USDA)’s implementing regulations,3 petitioner Center for Food Safety (CFS) respectfully submits this petition for agency action, rulemaking, and collateral relief on behalf of its over 350,000 farmer and consumer members, including alfalfa farmers Joseph and Michelle Peila. CFS requests that the Department retract its September 17, 2013 decision and take all regulatory action needed to remedy the current genetically engineered (GE) alfalfa contamination because its original decision was based on erroneous factual information—that the transgenic contamination occurred after GE Roundup Ready alfalfa was approved for commercial sale. In fact, records indicate that the seed used for the rejected contaminated alfalfa itself tested positive for Roundup Ready contamination, and this seed was purchased in 2010, before the deregulation of Roundup Ready alfalfa. CFS is a nationwide public interest non-profit membership organization with offices in Washington, D.C., San Francisco, CA, and Portland, OR. Since the organization’s founding in 1997, CFS has sought to ameliorate the adverse impacts of industrial farming and food production systems on human health, animal welfare, and the environment. CFS also supports and promotes sustainable forms of agriculture, including organic systems.
    [Show full text]
  • Plant Molecular Farming: a Viable Platform for Recombinant Biopharmaceutical Production
    plants Review Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production Balamurugan Shanmugaraj 1,2, Christine Joy I. Bulaon 2 and Waranyoo Phoolcharoen 1,2,* 1 Research Unit for Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] 2 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences Chulalongkorn University, Bangkok 10330, Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-2-218-8359; Fax: +66-2-218-8357 Received: 1 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional established expression systems based on bacteria or mammalian cell cultures. Since the advancements of plant genetic engineering in the 1980s, plants have been used for the production of economically valuable, biologically active non-native proteins or biopharmaceuticals, the concept termed as plant molecular farming (PMF). PMF is considered as a cost-effective technology that has grown and advanced tremendously over the past two decades. The development and improvement of the transient expression system has significantly reduced the protein production timeline and greatly improved the protein yield in plants. The major factors that drive the plant-based platform towards potential competitors for the conventional expression system are cost-effectiveness, scalability, flexibility, versatility, and robustness of the system. Many biopharmaceuticals including recombinant vaccine antigens, monoclonal antibodies, and other commercially viable proteins are produced in plants, some of which are in the pre-clinical and clinical pipeline.
    [Show full text]
  • Controlling Pregnancy: Fred Lyman Adair and the Influence of Eugenics on the Development of Prenatal Care
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2019 Controlling Pregnancy: Fred Lyman Adair And The nflueI nce Of Eugenics On The evelopmeD nt Of Prenatal Care Florence Hsiao Follow this and additional works at: https://elischolar.library.yale.edu/ymtdl Recommended Citation Hsiao, Florence, "Controlling Pregnancy: Fred Lyman Adair And The nflueI nce Of Eugenics On The eD velopment Of Prenatal Care" (2019). Yale Medicine Thesis Digital Library. 3504. https://elischolar.library.yale.edu/ymtdl/3504 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. Controlling Pregnancy: Fred Lyman Adair and the Influence of Eugenics on the Development of Prenatal Care A Thesis Submitted to the Yale University School of Medicine In Partial Fulfillment of the Requirements for the Degree of Doctor of Medicine By Florence Hsiao Class of 2019 Abstract This thesis examines the development of prenatal care in the United States in the early 1900s by focusing on the life and career of Fred Lyman Adair who, as an obstetrician and eugenicist, played a significant role in shaping prenatal care into what it is today. Although prenatal care was a product of infant welfare activists and public health officials, obstetricians like Adair who struggled to establish obstetrics as a legitimate specialty, saw an opportunity in prenatal care to pathologize pregnancy and elevate their specialty.
    [Show full text]
  • US EPA, Pesticide Product Label, WIDESTRIKE 3 INSECT
    UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION October 18, 2016 Stephanie L. Burton US Regulatory Manager Dow AgroSciences LLC 9330 Zionsville Road Indianapolis, IN 46268-1054 Subject: PRIA (Pesticide Registration Improvement Act) Amendment – to update the terms of registration related to gene flow and revise the product label. Product Name: WideStrike® 3 Insect Resistant Cotton EPA Registration Number: 68467-19 Application Date: June 23, 2016 OPP Decision Number: 518794 Dear Ms. Burton: The amendment referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended, are acceptable provided you comply with the revised terms of registration as set forth below: 1. Submit/cite all data required for registration of your product under FIFRA § 3(c)(5) when the Agency requires all registrants of similar products to submit such data. 2. Gene Flow The following information regarding commercial production must be included in the grower guide for WideStrike® 3 Insect Resistant Cotton: a) No planting of WideStrike® 3 Insect Resistant Cotton is permitted south of Route 60 (near Tampa) in Florida. b) Commercial culture of WideStrike® 3 Insect Resistant Cotton is prohibited in Hawaii, Puerto Rico, and the US Virgin Islands. The following information regarding test plots and seed production must appear in contracts or on bags of WideStrike® 3 Insect Resistant Cotton intended for the following purposes: Page 2 of 10 EPA Reg. No. 68467-19 OPP Decision No. 518794 a) Test plots or breeding nurseries, regardless of the plot size, established in Hawaii must not be planted within 3 miles of Gossypium tomentosum.
    [Show full text]
  • Position Statement on Genetically Engineered Food
    Position Statement on Genetically Engineered Food ealth Care Without Harm opposes the produc- Human Health Concerns tion and marketing of genetically engineered Few long-term studies have been conducted to assure that H(GE) foods. These foods are not adequately production and consumption of GE foods will carry no assessed for their credible adverse effects on human or adverse long-term health impacts. A 2003 peer-reviewed animal health, or on the environment in which they are literature search found just ten published studies specifi- produced. Also of concern is the threat posed by genetic cally designed to assess the potential for health effects engineering to environmentally sustainable food produc- from GE foods or feed.4 For hospitals, patient health is tion and the threat to the economic livelihood of farmers of particular concern, since some patients may be more pursing sustainable food production. vulnerable to possible problems from GE foods than the We therefore encourage health care providers to purchase general public. For example, full digestion of proteins de- non-GE foods to the extent possible and to source from creases the likelihood they will survive to produce harm suppliers that demonstrate a strong commitment to al- (via direct toxicity or allergenicity), whereas digestive ternatives to GE food, and that support local farmers and function is sometimes compromised in hospital patients. sustainable practices. The immune system in such patients may also be compro- mised, making them more generally susceptible to harm. Background Allergies: Genetic engineering moves proteins novel For about a decade,1 companies have introduced geneti- to the human diet into the food supply.
    [Show full text]
  • AHFS Pharmacologic-Therapeutic Classification System
    AHFS Pharmacologic-Therapeutic Classification System Abacavir 48:24 - Mucolytic Agents - 382638 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Acitretin 84:92 - Skin and Mucous Membrane Agents, Abaloparatide 68:24.08 - Parathyroid Agents - 317036 Aclidinium Abatacept 12:08.08 - Antimuscarinics/Antispasmodics - 313022 92:36 - Disease-modifying Antirheumatic Drugs - Acrivastine 92:20 - Immunomodulatory Agents - 306003 4:08 - Second Generation Antihistamines - 394040 Abciximab 48:04.08 - Second Generation Antihistamines - 394040 20:12.18 - Platelet-aggregation Inhibitors - 395014 Acyclovir Abemaciclib 8:18.32 - Nucleosides and Nucleotides - 381045 10:00 - Antineoplastic Agents - 317058 84:04.06 - Antivirals - 381036 Abiraterone Adalimumab; -adaz 10:00 - Antineoplastic Agents - 311027 92:36 - Disease-modifying Antirheumatic Drugs - AbobotulinumtoxinA 56:92 - GI Drugs, Miscellaneous - 302046 92:20 - Immunomodulatory Agents - 302046 92:92 - Other Miscellaneous Therapeutic Agents - 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous - Adapalene 84:92 - Skin and Mucous Membrane Agents, Acalabrutinib 10:00 - Antineoplastic Agents - 317059 Adefovir Acamprosate 8:18.32 - Nucleosides and Nucleotides - 302036 28:92 - Central Nervous System Agents, Adenosine 24:04.04.24 - Class IV Antiarrhythmics - 304010 Acarbose Adenovirus Vaccine Live Oral 68:20.02 - alpha-Glucosidase Inhibitors - 396015 80:12 - Vaccines - 315016 Acebutolol Ado-Trastuzumab 24:24 - beta-Adrenergic Blocking Agents - 387003 10:00 - Antineoplastic Agents - 313041 12:16.08.08 - Selective
    [Show full text]
  • Monsanto Company in Microsoft Word Format Together with a Copy of the Transmittal Letter That Accompanies the Filing of Two Paper Copies of the Submission
    From: Letzler, Kenneth [mailto:[email protected]] Sent: Thursday, December 31, 2009 1:03 PM To: ATR-Agricultural Workshops Subject: Comment Attached please find a comment submitted on behalf of Monsanto Company in Microsoft Word format together with a copy of the transmittal letter that accompanies the filing of two paper copies of the submission. _____________________________ U.S. Treasury Circular 230 Notice Any U.S. federal tax advice included in this communication (including any attachments) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding U.S. federal tax-related penalties or (ii) promoting, marketing or recommending to another party any tax-related matter addressed herein. _____________________________ This communication may contain information that is legally privileged, confidential or exempt from disclosure. If you are not the intended recipient, please note that any dissemination, distribution, or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer. ---------------------------------------------------------------------- For more information about Arnold & Porter LLP, click here: http://www.arnoldporter.com Competition and Innovation in American Agriculture A Response to the American Antitrust Institute’s “Transgenic Seed Platforms: Competition Between a Rock and a Hard Place?” Submitted on Behalf of Monsanto Company In Response to the Request for Comments by the United States Department of Agriculture and United States Department of Justice, Antitrust Division, in Connection with Their Hearings on “Agriculture and Antitrust Enforcement Issues in Our 21st Century Economy” Vandy Howell, Ph.D.
    [Show full text]
  • SUMMARY Sign Offv7
    Syngenta Event GA21 Page 1 of 29 PART II: SUMMARY Application for import and use of genetically modified herbicide tolerant maize Event GA21 under Regulation (EC) No 1829/2003 PART II: SUMMARY Syngenta Event GA21 Page 2 of 29 PART II: SUMMARY A . GENERAL INFORMATION 1. Details of application a) Member State of application UK b) Application number Not available at the time of submission c) Name of the product (commercial and other names) Maize Event GA21 In the USA, GA21 is marketed under the product name Agrisure GT Advantage (http://www.nk-us.com/infosilo/seedguide/agrisure.asp) d) Date of acknowledgement of valid application Not available at the time of submission Syngenta Event GA21 Page 3 of 29 PART II: SUMMARY 2. Applicant a) Name of applicant Syngenta Seeds S.A.S on behalf of Syngenta Crop Protection AG, Basel b) Address of applicant Syngenta Seeds S.A.S. 12, chemin de l'Hobit BP 27 F-31790 Saint-Sauveur On behalf of Syngenta Crop Protection AG, Basel Switzerland and all affiliated companies Schwarzwaldallee 215 CH 4058 Basle Switzerland c) Name and address of the person established in the Community who is responsible for the placing in the market, whether it be the manufacturer, the importer or the distributor, if different from the applicant (Commission Decision 2004/204/EC Art 3(a)(ii)) Event GA21 maize will be imported and used as any other maize in the EU by operators currently involved in these processes. 3. Scope of the application x GM plants for food use x Food containing or consisting of GM plants xFood produced from GM plants or containing ingredients produced from GM plants xGM plants for feed use x Feed containing or consisting of GM plants x Feed produced from GM plants x Import and processing (Part C of Directive 2001/18/EC) o Seeds and plant propagating material for cultivation in Europe (Part C of Directive 2001/18/EC) Syngenta Event GA21 Page 4 of 29 PART II: SUMMARY 4.
    [Show full text]
  • The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-Dupont, and Chemchina-Syngenta
    Research Brief October 2018 The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-DuPont, and ChemChina-Syngenta DISRUPT ECOSYSTEM ACCLERATE MONOPOLY THE EFFECTS OF CORPORATE CONSOLIDATION UNDERMINE FOOD SECURITY HARM SMALL PRODUCERS HAASINSTITUTE.BERKELEY.EDU This publication is published by the Haas Institute for a Fair and Inclusive Society at UC Berkeley This research brief is part of the Haas Institute's Shahidi Project from the Global Justice Program. The Shahidi Project (Shahidi is a Swahili word meaning “witness”) intends to demystify the power structures and capacities of transnational food and agricultural corporations within our food system. To that end, researchers have developed a robust database focusing on ten of the largest food and agricultural corporations in the world. See more at haasinstitute.berkeley.edu/shahidi. About the Authors Copyeditor Support Elsadig Elsheikh is the director Marc Abizeid Special thanks to the Food of the Global Justice program and Farm Communications at the Haas Institute for a Infographics Fund, which provided the seed Fair and Inclusive Society at Samir Gambhir funding for the Shahidi project. the University of California- Berkeley, where he oversees Report Citation Contact the program’s projects and Elsadig Elsheikh and Hossein 460 Stephens Hall research on corporate power, Ayazi. “The Era of Corporate Berkeley, CA 94720-2330 food system, forced migration, Consolidation and The End of Tel 510-642-3326 human rights, Islamophobia, Competition: Bayer-Monsanto, haasinstitute.berkeley.edu structural marginality and Dow-DuPont, and ChemChina- inclusion, and trade and Syngenta.” Haas Institute for development. a Fair and Inclusive Society at the University of California, Hossein Ayazi, PhD, is a Berkeley, CA.
    [Show full text]